Recipharm in regulatory partnership

CDMO Recipharm has formed a strategic collaboration that will combine its integrated development and manufacturing capabilities across small molecules, traditional biologics and advanced therapies medicinal products with the expertise of ProductLife Group (PLG) in product development, regulatory affairs and market access. Recipharm employs about 700 in product development and delivers about 400 projects/year while PLG has 2,000 regulatory experts operating across 150 countries.

Their stated aim is to support (bio)pharmaceutical companies to accelerate time to clinical trials and market approval while reducing supply chain, compliance and regulatory challenges during product development. “By combining forces, the two companies will ensure customers receive comprehensive support from early-stage development to approval and market access, which will result in earlier availability of medicines to the market,” Recipharm said.